ACE2 and infection: Using three independent animal models, including a new hybrid human/mouse ACE2 knock-in mouse, the evidence presented herein unambiguously indicates that mice lacking surface-expressed and circulating immunoglobulins—yet retaining functional B cells and intact secondary lymphoid organs—are capable of resisting heterologous SARS-CoV-2 challenges post prior infection or mRNA vaccination.